Study to Determine the Maximum Tolerated Dose (MTD) of PARPi 2X-121 Monotherapy and the MTD of Dovitinib in Combination With 2X-121 in Patients With Advanced Solid Tumors
- Status
- SUSPENDED
- Phase
- PHASE1
Clinical Trials Related to Advanced Solid Tumors
Related studies linked through entity extraction aliases.
A Study of FDA022-BB05 in Subjects With Advanced Solid Malignant Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Study of YH004 (4-1BB Agonist Antibody) in Advanced Solid Tumors And Relapsed Or Refractory Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
A Study of ASKG315 in Patients With Advanced Solid Tumors.
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of Intratumoral KL340399 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation
- Status
- RECRUITING
- Phase
- PHASE2
Evaluate the Safety, Tolerability, and Pharmacokinetics of ICP-723 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase 1 Study of ASKG315 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of Duvelisib Combined With SG001 Injection in Patient With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Clinical Study to Evaluate the Safety, Tolerability,JS019 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced or Metastatic Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Study of Relatlimab in Combination With Nivolumab in Chinese Participants
- Status
- COMPLETED
- Phase
- PHASE1
First-In-Human Study in Subjects With Advanced or Metastatic Solid Malignant Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of HRS-1167 as Monotherapy in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study Explore WJ01075 Tablets in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Safety of Navoximod and NLG802 With Stereotactic Body Radiotherapy (SBRT) Treatment of Advanced Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1